NEUVOGEN today announced that Todd Binder , Chief Executive Officer of NEUVOGEN, will participate in the B. Riley Virtual Oncology Investor Conference: B. Riley Virtual Oncology Investor Conference Date: Thursday, January 21, 2021 Time: 3:00 PM Eastern Time https://www.webcaster4.com/Webcast/Page/2433/39715 About NEUVOGE
SAN DIEGO, Jan. 20, 2021 /PRNewswire/ -- NEUVOGEN today announced that Todd Binder, Chief Executive Officer of NEUVOGEN, will participate in the B. Riley Virtual Oncology Investor Conference: B. Riley Virtual Oncology Investor Conference About NEUVOGEN
View original content:http://www.prnewswire.com/news-releases/neuvogen-announces-participation-at-b-riley-virtual-oncology-investor-conference-301211897.html SOURCE NEUVOGEN Inc. |